“Oppenheimer” is a reminder to physicians, scientists to act to prevent nuclear war

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Now I Am Become Death, the Destroyer of Worlds.Bhavagad GIta

Many readers of The Cancer Letter will have seen or at least be aware of the buzz surrounding release of the new “Oppenheimer” movie, which has received excellent reviews.

Now that 78 years have passed since the first A-bomb exploded, we find many people, perhaps most, with little or no knowledge of the details. This is especially true for physicians and scientists. 

There is a recent global effort to have medical journals publish statements on physicians’ social responsibility in the face of the increasing threat of a nuclear war. A copy of the statement is available in the first reference. 1 

In this editorial, we hope to increase readers’ knowledge and impress on them their social responsibility to consider and try to mitigate the threat of nuclear war.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM
Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London
Andrea Hochhaus, MD
Klinik für Innere Medizin II, Universitätsklinikum Jena; Comprehensive Cancer Center Central Germany, Jena, Germany
Table of Contents

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM
Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London
Andrea Hochhaus, MD
Klinik für Innere Medizin II, Universitätsklinikum Jena; Comprehensive Cancer Center Central Germany, Jena, Germany

Login